Asean Strategy - JPM PDF
Asean Strategy - JPM PDF
Asean Strategy - JPM PDF
09 April 2020
At the risk of sounding repetitive, we reiterate our cautious stance on Southeast Asia Equity Strategy
ASEAN equities. We acknowledge that this is now a consensus view but we
Rajiv Batra AC
expect equities to continue to decline as GDP and EPS are revised lower. (65) 6882-8151
Valuations look attractive but we caution that current forward P/E multiples [email protected]
appear too low considering that the denominators are likely still high. Bloomberg JPMA BATRA <GO>
Policymakers’ response has stepped up materially via a combination of J.P. Morgan Securities Singapore Private
monetary easing and fiscal support to ease tightened household and corporate Limited
cash flows. The path ahead seems to be bifurcated between the path of the virus Hoy Kit Mak
and the impact of the support policies on the economy. This report reviews (60-3) 2718-0713
GDP/EPS revisions (page 6), bond/FX movements (page 7), and [email protected]
regional/country valuations. JPMorgan Securities (Malaysia) Sdn. Bhd.
(18146-X)
In this note, we revise the targets for the MSCI and the local indices in the Jeanette Yutan
six countries that we cover in the ASEAN region (see page 9 to 14 for (63-2) 8878-1188
[email protected]
base/bull/bear scenario at country level). Most ASEAN countries except
J.P. Morgan Securities Philippines, Inc.
Thailand are trading well below their historical valuations, making it a
challenge to pick target multiples. We assume re-rating to 10 year average Henry Wibowo
levels for majority of markets in the base case scenario. In the bull case (622-1) 5291 8526
[email protected]
scenario, we assume markets re-rate to +1SD levels. In the bear case, we
PT J.P. Morgan Sekuritas Indonesia
assume multiples go back to 10 year trough levels.
EM Equity Strategist
Consensus earnings expectations are too high, in our view. Be aware of Pedro Martins Junior, CFA
companies’ operational leverage and the impact of difficult credit conditions on (55-11) 4950-4121
profits. We believe that stock, rather than market specific risk, will dominate [email protected]
over the next two quarters as investors focus on companies’ success in Banco J.P. Morgan S.A.
navigating a tough environment. Anindita Gandhi
(91-22) 6157-3248
We would be selective buyers within ASEAN equities, albeit with a defensive [email protected]
bias. We recommend focusing on adding positions in companies with strong J.P. Morgan India Private Limited
balance sheets and strong earnings growth profiles. Please see Table 14 for our Jainik Mody, CFA
top picks in ASEAN. Our preferred sectors are consumer staples, telecom and (44 20) 3493-0443
good quality banks. [email protected]
J.P. Morgan Securities plc
When will we turn bullish? This will largely depend on whether we see the
following: stabilizing virus infection curves globally, no negative spiral which
is typical of recessions, and the IMF and central banks act promptly to provide
dollar liquidity to the key EM economies.
See page 15 for analyst certification and important disclosures, including non-US analyst disclosures.
J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the
firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in
making their investment decision.
www.jpmorganmarkets.com
This document is being provided for the exclusive use of [email protected].
Rajiv Batra Asia Pacific Equity Research
(65) 6882-8151 09 April 2020
[email protected]
Much of the global stimulus came in the form of loans 5. Lower commodity prices provide some margin
rather than grants. Loans are better than nothing, but it pressure relief for manufacturers. But watch for
will add to the debt overhang problem for the business inventory write-downs and a collapse in material
sector. There could be material spillovers in the DM from margins.
the severe services sector retrenchment to final goods In the near term, a few ASEAN countries may benefit
demand, with a knock-on to corporate behavior from a reduction in risk premium as Singapore is
especially given that global capex started the year on a expected to be the first to see a peak, in early April,
soft footing. followed by Malaysia and Thailand in mid-April, as per
the epidemiology model from MW Kim, Ling Wang &
In this note, we revise the targets for the MSCI and team. However, even as China’s manufacturing sector
the local indices in the six countries that we cover in normalizes, we now face a third shock, the global
the ASEAN region (see page 9 to 14 for base/bull/bear recession. In this regard, open economies like Singapore,
scenario at country level). Most ASEAN countries Thailand and Malaysia will be more deeply impacted
except Thailand are trading well below their historical compared to those that are more domestically driven.
valuations, making it a challenge to pick target multiples. Note, even domestic driven economies like Indonesia and
We assume re-rating to 10 year average levels for the Philippines will suffer in the near/medium term as
majority of markets in the base case scenario. In the bull government containment measures against Covid-19
case scenario, we assume markets re-rate to +1SD levels. have led to closure or limited operations of commercial
In the bear case, we assume multiples go back to 10 year establishments such as shopping malls, restaurants, and
trough levels. non-essential outlets/stores. We also believe that a
second order impact on consumption, i.e. deep job losses
We used bottom up and top down earnings from both J.P. could reinforce or re-shape consumer behavior (see page
Morgan and consensus to derive our base case for 8). Hence underperformance of ASEAN is likely to
earnings. Underlying this assumption is the view that the continue versus AxJ, in our view.
pandemic should crest in early 2Q20, providing the
tailwinds for recovery in 2H20. In the event that this We would be selective buyers within ASEAN equities,
assumption proves too optimistic, material downside albeit with a defensive bias. We recommend focusing on
remains for the region. adding positions in companies with strong balance sheets
and strong earnings growth profiles. Please see Table 14
Economic revisions for Asia have gone through several for the top picks in ASEAN. Our preferred sectors are
iterations since the beginning of the COVID-19 outbreak. consumer staples, telecom and good quality banks.
J.P .Morgan’s economic team is forecasting a recession
in Singapore, Thailand and Malaysia. GDP growth for When will we turn bullish? This will largely depend on
other ASEAN countries is significantly below potential. whether we see the following: stabilizing virus infection
However consensus earnings expectations are still too curves globally, no negative spiral which is typical of
high relative to the macro backdrop. The drivers for recessions, and the IMF and central banks act promptly
further downward revisions are: to provide dollar liquidity to the key EM economies.
Malaysia
Thailand
Vietnam
EM Asia
Philippines
Source: J.P. Morgan estimates.
EM
Singapore
GDP growth revision Figure 5: Current J.P. Morgan vs. Consensus Forecasts for 2020
J.P. Morgan 2020 GDP estimates have been revised GDP (%)
down across the board in the face of COVID-19
pandemic (see Table 6). US and Australia saw the Hong Kong
highest downward revision to 2020 GDP estimates YTD Korea
at -7.0% and -6.7% respectively, closely followed by Euro Area
Thailand at -6.1%. Korea (-1.5%), Hong Kong (-1.7%),
Taiwan
and Taiwan (-1.9%) suffered the least downward revision
YTD to 2020 GDP forecasts likely on the back of China
prudent policies and limited industrial shutdown in the Indonesia
face of the epidemic. However, the supply chain Singapore
disruption is unlikely to leave these export oriented
Japan
economies unscathed.
Australia
J.P. Morgan estimates for 2020 GDP are significantly India
lower than consensus for most economies with the Thailand
exception of Hong Kong (+0.5%) and Korea (in-line).
US
2020 GDP deviation between J.P. Morgan estimates and
consensus estimates is largest in the Philippines and Malaysia
Malaysia (-5.1% each, see Figure 5). Philippines
China
Most other currencies are forecasted to climb back by Singapore
0.3% to 1.2% during the rest of 2020.
HK
Philippines
FX Reserves
China had the largest decrease in FX reserves YTD. With U.S.
US$47bn decrease, followed by South Korea (-$8.6bn) -2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 2.0
and Hong Kong (-$3.8bn). Singapore, Philippines, and Source: Bloomberg Data. , 8 April 2020. Note: Sorted by change from 2019 average.
Malaysia saw a slight drop in reserves while most other
countries have accumulated their FX reserves during the Figure 8: Change in exchange rate vs. USD (%)
first few months of 2020.
TWD
CNY
EUR
SGD
KRW
MYR
THB
INR
Source: National sources. IDR
Singapore
Investment thesis Figure 13: MSCI Singapore with bull, base and bear case line
Escalation of COVID-19 infections, fears of deep global 480 MSCI Singapore Base Bull Bear
recession and liquidity shortage resulted in a broad-based 430
sell-off across global equity markets, including
Singapore. But MSCI Singapore is outperforming 380
ASEAN by 3% year to date. We believe Singapore is
330
better prepared in tackling the virus compared to
previous outbreaks (SARS and HIN1). Singapore has 280
applied rigorous preventive measures to combat the
230
Covid-19 outbreak and has been praised by WHO for its
effective containment. Government announced the third 180
stimulus package (April 6) in two months amounting to 08 09 10 11 12 13 14 15 16 17 18 19 20
S$5.1 billion (US$3.6 billion), taking the nation’s total Source: Bloomberg, J.P. Morgan, 8 April 2020. Note: Chart show MSCI Singapore local
fiscal support to S$60 billion (12% of GDP). Given the currency index
2.4
Surge in property demand which leads to positive 5.0
0.0
earnings for developers, and feeds through by a (5.0) (2.3) (2.1)
wealth effect to domestic demand (10.0)
(4.4)
(7.4)
(9.0)
(10.3)
Lower than expected asset quality concerns and (15.0)
06
(12.7)
07 08 09 10 11 12 13 14 15 16 17 18 19 20 21
modest declines in margins
Source: IBES, DataStream; J.P. Morgan. Note, 2020-21 is consensus forecast
Bear case
Long tail of COVID-19 or resurgence. Table 9: JPM vs consensus EPS growth forecasts
Singapore Weight J.P. Morgan Consensus
Tighter or more volatile global financial conditions (%) 2020 2021 2020 2021
Total Market 100 (20.3) 9.7 (7.4) 11.8
could lead to stress on leveraged firms and Consumer Discretionary 3.2 (13.8) 20.3 (25.2) 34.6
households Consumer Staples 3.2 (5.8) 12.6 1.4 8.7
Financials 48.1 (36.0) 5.7 (15.2) 9.7
A large and disorderly property price correction and Industrials 12.6 (7.4) 16.4 0.4 27.8
Information Technology 1.9 0.6 8.4 (0.5) 7.4
feeds through adverse wealth effects on households Real Estate 18.8 (1.1) 13.2 13.5 7.7
Communication Services 12.2 (1.4) 10.4 17.4 7.5
Higher slippages and credit cost Source: MSCI, IBES, Datastream, J.P. Morgan
Indonesia
Investment Thesis Figure 16: MSCI Indonesia with bull, base and bear case line
YTD, JCI fell 27% with Rupiah weakening 17% at now 8500 MSCI Indonesia Base Bull Bear
that it will lift the 3% deficit cap for 3yrs (2020-2022) to 3500
provide social assistance and other support as the country 2500
battles the COVID-19 pandemic. We believe this is a 1500
positive development taken by the Government to allow 08 09 10 11 12 13 14 15 16 17 18 19 20
for much bigger stimulus and social assistance to the Source: Bloomberg, J.P. Morgan. 8 April 2020. Note: Chart show MSCI Indonesia local
consumer/business impacted by COVID-19. However, it currency index
should be stressed that these are unprecedented times and
in as much as these pressures are short term, there is no Figure 17: Forward P/E
reason to think that these measures will be extended 18.0
10
The Philippines
Investment Thesis Figure 19: MSCI Philippines with bull, base and bear case line
We think the Philippines faces an imminent recession 1700 MSCI Philippines Base Bull Bear
risk given that all GDP components are adversely 1500
affected, and considering the Philippines infection curve
1300
is still at its early stage. Recall that the 1991/1998
recession was due to weak investments and gov't 1100
spending whereas current crisis is expected to see a 900
slowdown in household consumption (~65% of GDP).
700
Note, Philippines was the first ASEAN nation to
implement a stringent “quarantine” policy in mid-March 500
and this was subsequently extended by two more weeks 300
until end of April amid low testing capacity. This was 08 09 10 11 12 13 14 15 16 17 18 19 20
accompanied by BSP’s aggressive monetary policy Source: Bloomberg, J.P. Morgan. 8 April 2020. Note: Chart show MSCI Philippines local
support and fiscal stimulus package amounting to currency index
Php278bn. Philippines equities lost close to 29% YTD,
post 19% rebound from March lows. Market PE is at Figure 20: Forward P/E
10.9x, still >15% away from the GFC trough. However, 22.0
11
Thailand
Investment thesis Figure 22: MSCI Thailand with bull, base and bear case line
SET tumbled by 24% YTD, MSCI Thailand lost 30% 700 MSCI Thailand Base Bull Bear
Massive FDI flows due to supply chain shift. Table 12: JPM vs consensus EPS growth forecasts
Thailand Weight J.P. Morgan Consensus
Bear case (%) 2020 2021 2020 2021
Continued virus spread within Thailand that Total Market 100 (12.8) 16.9 (5.5) 15.3
Consumer Discretionary 4.7 (9.5) 6.3 (35.9) 33.3
prolongs disruption of economic activities. Consumer Staples 16.7 21.0 11.2 15.8 10.2
Energy 15.4 (25.0) 25.2 (10.4) 17.4
Deeper recession in Developed markets Financials 10.8 (20.6) 9.4 (12.1) 14.1
Health Care 6.8 (42.9) 45.0 6.0 12.9
Industrials 9.8 (28.6) 35.7 (20.2) 33.6
Continued delay in implementation/execution of Materials 10.5 11.6 17.8 11.3 21.6
government investments to weigh on GDP growth. Real Estate 4.3 (32.4) 36.3 (12.8) 13.7
Communication Services 11.9 (2.8) 6.6 (4.9) 2.2
Utilities 9.2 (0.9) 16.6 7.9 10.6
Delay in growth recovery as a result of the droughts.
Source: MSCI, IBES, Datastream, J.P. Morgan
12
Malaysia
Investment thesis Figure 25: MSCI Malaysia with bull, base and bear case line
The KLCI is 15% lower YTD amid the global COVID- 700 MSCI Malaysia Base Bull Bear
19 crisis and 23% lower from peak in February 2019. 650
Though Malaysia is a consensus UW market, downside 600
risk remains, given heavy reliance on trade amid a global 550
recession, lower oil, and near-term impact from COVID- 500
19. Investors are assessing impact on earnings, cash
450
flows, and corporate balance sheet. In a demand shock
situation, fiscal policy is the most appropriate tool in our 400
13
Vietnam
Investment thesis Figure 28: VN-Index with bull, base and bear case line
The COVID-19 sent a shockwave to global markets, 1400 VN-Index Base Bull Bear
sending VN-Index & MSCI Vietnam down by 23%
1200
YTD. On relative terms, Vietnam equities outperformed
MSCI ASEAN (-30% YTD) and MSCI Frontier Markets 1000
(-31% YTD) during this sell off. This prompted
800
governments around world to apply aggressive measures
to restrain the virus spread. This shock would push global 600
economy into a recession. Vietnam 1Q20 GDP growth is
3.8% y/y - lowest since the GFC. Despite the gloomy 400
prospects, we are seeing some silver linings from 200
Vietnam with signs of support in the near term: (1) 08 09 10 11 12 13 14 15 16 17 18 19 20
Aggressive measures helped to contain virus spread: Source: Bloomberg, J.P. Morgan. 8 April 2020.
Vietnam have a lowest number of confirmed cases
among ASEAN-6 countries despite having number of Figure 29: Forward P/E – MSCI Vietnam
tests; (2) Rate cuts (100bps) and fiscal support including 30.0
a VND 80Tn (1.2% GDP) in tax breaks, payroll support
in the short term and acceleration of public investment 25.0
(VND 460Tn – 7.8% GDP) in the medium term; and (3)
early recovery of China and Korea will benefit Vietnam. 20.0
Market valuation is at a discount compared to the 2008
GFC. We stay OW Vietnam within ASEAN, 15.0
positioning for the transition to recovery phase. We
prefer banks, IT, consumer staples, and utilities from 10.0
14
15
Important Disclosures
MSCI: The MSCI sourced information is the exclusive property of MSCI. Without prior written permission of MSCI, this information
and any other MSCI intellectual property may not be reproduced, redisseminated or used to create any financial products, including any
indices. This information is provided on an 'as is' basis. The user assumes the entire risk of any use made of this information. MSCI, its
affiliates and any third party involved in, or related to, computing or compiling the information hereby expressly disclaim all warranties of
originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of this information. Without
limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in, or related to, computing or
compiling the information have any liability for any damages of any kind. MSCI and the MSCI indexes are services marks of MSCI and
its affiliates.
Company-Specific Disclosures: Important disclosures, including price charts and credit opinion history tables, are available for
compendium reports and all J.P. Morgan–covered companies by visiting https://www.jpmm.com/research/disclosures, calling 1-800-477-
0406, or e-mailing [email protected] with your request. J.P. Morgan’s Strategy, Technical, and Quantitative
Research teams may screen companies not covered by J.P. Morgan. For important disclosures for these companies, please call 1-800-477-
0406 or e-mail [email protected].
Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe:
J.P. Morgan uses the following rating system: Overweight [Over the next six to twelve months, we expect this stock will outperform the
average total return of the stocks in the analyst’s (or the analyst’s team’s) coverage universe.] Neutral [Over the next six to twelve
months, we expect this stock will perform in line with the average total return of the stocks in the analyst’s (or the analyst’s team’s)
coverage universe.] Underweight [Over the next six to twelve months, we expect this stock will underperform the average total return of
the stocks in the analyst’s (or the analyst’s team’s) coverage universe.] Not Rated (NR): J.P. Morgan has removed the rating and, if
applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy
reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a
recommendation or a rating. In our Asia (ex-Australia and ex-India) and U.K. small- and mid-cap equity research, each stock’s expected
total return is compared to the expected total return of a benchmark country market index, not to those analysts’ coverage universe. If it
does not appear in the Important Disclosures section of this report, the certifying analyst’s coverage universe can be found on J.P.
Morgan’s research website, www.jpmorganmarkets.com.
Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered
companies, please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst
or your J.P. Morgan representative, or email [email protected]. For material information about the proprietary
16
models used, please see the Summary of Financials in company-specific research reports and the Company Tearsheets, which are
available to download on the company pages of our client website, http://www.jpmorganmarkets.com. This report also sets out within it
the material underlying assumptions used.
Analysts' Compensation: The research analysts responsible for the preparation of this report receive compensation based upon various
factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues.
Registration of non-US Analysts: Unless otherwise noted, the non-US analysts listed on the front of this report are employees of non-US
affiliates of J.P. Morgan Securities LLC, may not be registered as research analysts under FINRA rules, may not be associated persons of
J.P. Morgan Securities LLC, and may not be subject to FINRA Rule 2241 or 2242 restrictions on communications with covered
companies, public appearances, and trading securities held by a research analyst account.
Other Disclosures
J.P. Morgan is a marketing name for investment banking businesses of JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide.
All research reports made available to clients are simultaneously available on our client website, J.P. Morgan Markets. Not all research content is
redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your sales
representative.
Any data discrepancies in this report could be the result of different calculations and/or adjustments.
Any long form nomenclature for references to China; Hong Kong; Taiwan; and Macau within this research report are Mainland China; Hong Kong SAR,
China; Taiwan, China; Macau SAR, China.
Options and Futures related research: If the information contained herein regards options or futures related research, such information is available only
to persons who have received the proper options or futures risk disclosure documents. Please contact your J.P. Morgan Representative or visit
https://www.theocc.com/components/docs/riskstoc.pdf for a copy of the Option Clearing Corporation's Characteristics and Risks of Standardized Options
or http://www.finra.org/sites/default/files/Security_Futures_Risk_Disclosure_Statement_2018.pdf for a copy of the Security Futures Risk Disclosure
Statement.
Changes to Interbank Offered Rates (IBORs) and other benchmark rates: Certain interest rate benchmarks are, or may in the future become, subject
to ongoing international, national and other regulatory guidance, reform and proposals for reform. For more information, please consult:
https://www.jpmorgan.com/global/disclosures/interbank_offered_rates
Private Bank Clients: Where you are receiving research as a client of the private banking businesses offered by JPMorgan Chase & Co. and its
subsidiaries (“J.P. Morgan Private Bank”), research is provided to you by J.P. Morgan Private Bank and not by any other division of J.P. Morgan,
including but not limited to the J.P. Morgan corporate and investment bank and its research division.
Legal entity responsible for the production of research: The legal entity identified below the name of the Reg AC research analyst who authored this
report is the legal entity responsible for the production of this research. Where multiple Reg AC research analysts authored this report with different legal
entities identified below their names, these legal entities are jointly responsible for the production of this research.
17
MB/INM000002970). Telephone: 91-22-6157 3000, Facsimile: 91-22-6157 3990 and Website: www.jpmipl.com. For non local research reports, this
material is not distributed in India by J.P. Morgan India Private Limited. Thailand: This material is issued and distributed in Thailand by JPMorgan
Securities (Thailand) Ltd., which is a member of the Stock Exchange of Thailand and is regulated by the Ministry of Finance and the Securities and
Exchange Commission and its registered address is 3rd Floor, 20 North Sathorn Road, Silom, Bangrak, Bangkok 10500. Indonesia: PT J.P. Morgan
Sekuritas Indonesia is a member of the Indonesia Stock Exchange and is regulated by the OJK a.k.a. BAPEPAM LK. Philippines: J.P. Morgan Securities
Philippines Inc. is a Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the
Securities Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Brazil: Banco J.P. Morgan S.A. is regulated by the
Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Mexico: J.P. Morgan Casa de Bolsa, S.A. de C.V., J.P. Morgan Grupo
Financiero is a member of the Mexican Stock Exchange and authorized to act as a broker dealer by the National Banking and Securities Exchange
Commission. Singapore: This material is issued and distributed in Singapore by or through J.P. Morgan Securities Singapore Private Limited (JPMSS)
[MCI (P) 018/04/2020 and Co. Reg. No.: 199405335R], which is a member of the Singapore Exchange Securities Trading Limited and/or JPMorgan Chase
Bank, N.A., Singapore branch (JPMCB Singapore) [MCI (P) 070/09/2019], both of which are regulated by the Monetary Authority of Singapore. This
material is issued and distributed in Singapore only to accredited investors, expert investors and institutional investors, as defined in Section 4A of the
Securities and Futures Act, Cap. 289 (SFA). This material is not intended to be issued or distributed to any retail investors or any other investors that do not
fall into the classes of “accredited investors,” “expert investors” or “institutional investors,” as defined under Section 4A of the SFA. Recipients of this
document are to contact JPMSS or JPMCB Singapore in respect of any matters arising from, or in connection with, the document. Japan: JPMorgan
Securities Japan Co., Ltd. and JPMorgan Chase Bank, N.A., Tokyo Branch are regulated by the Financial Services Agency in Japan. Malaysia: This
material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X) which is a Participating Organization of Bursa
Malaysia Berhad and a holder of Capital Markets Services License issued by the Securities Commission in Malaysia. Pakistan: J. P. Morgan Pakistan
Broking (Pvt.) Ltd is a member of the Karachi Stock Exchange and regulated by the Securities and Exchange Commission of Pakistan. Dubai: JPMorgan
Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial Services Authority (DFSA) and its registered address is Dubai International Financial
Centre - Building 3, Level 7, PO Box 506551, Dubai, UAE. Russia: CB J.P. Morgan Bank International LLC is regulated by the Central Bank of Russia.
Argentina: JPMorgan Chase Bank Sucursal Buenos Aires is regulated by Banco Central de la República Argentina (“BCRA”- Central Bank of Argentina)
and Comisión Nacional de Valores (“CNV”- Argentinian Securities Commission”)
General: Additional information is available upon request. Information has been obtained from sources believed to be reliable but JPMorgan Chase & Co.
or its affiliates and/or subsidiaries (collectively J.P. Morgan) do not warrant its completeness or accuracy except with respect to any disclosures relative to
18
JPMS and/or its affiliates and the analyst's involvement with the issuer that is the subject of the research. All pricing is indicative as of the close of market
for the securities discussed, unless otherwise stated. Opinions and estimates constitute our judgment as of the date of this material and are subject to change
without notice. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any
financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not
intended as recommendations of particular securities, financial instruments or strategies to particular clients. The recipient of this report must make its own
independent decisions regarding any securities or financial instruments mentioned herein. JPMS distributes in the U.S. research published by non-U.S.
affiliates and accepts responsibility for its contents. Periodic updates may be provided on companies/industries based on company specific developments or
announcements, market conditions or any other publicly available information. Clients should contact analysts and execute transactions through a J.P.
Morgan subsidiary or affiliate in their home jurisdiction unless governing law permits otherwise.
19
Completed 09 Apr 2020 03:44 AM HKT Disseminated 09 Apr 2020 03:45 AM HKT
This document is being provided for the exclusive use of [email protected].